is imcivree a glp-1 Melanocortin Signalling Cascade. Various peripheral signals, such as Rhythm Pharmaceuticals' IMCIVREE becomes the

Amgen's MariTide is the second monthly-dosed obesity injection now in Phase 3, and the readouts that will determine whether it competes with retatrutide and the GLP-1 weekly class are tracking to early 2027

The meta-analyses in this age group show clear benefits for lean mass preservation and functional strength

While GLP-1 medicines are already transforming diabetes and obesity care, scientists now hope future clinical trials will determine whether they can also become part of treatment strategies for depression, bipolar disorder, and other mental health conditions

This chronic caloric excess eventually overwhelms the storage capacity of visceral adipose tissue, leading to adipose tissue failure